Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA

Anticancer Research

Volumn 20, Issue 6 A, 2000, Pages 4067-4071

  Kuroki, M ^a   Arakawa, F ^a   Khare, P D ^a   Liao, S ^a   Matsumoto, H ^a   Abe, H ^a   Imakiire, T ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CEA; Chimeric envelope protein; Chimeric T cell receptor; Gene therapy; scFv

Indexed keywords

B7 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD3 ANTIGEN; CHIMERIC ANTIBODY; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN FRAGMENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F11 39; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANIMALS; ANTIBODY AFFINITY; CARCINOEMBRYONIC ANTIGEN; GENE THERAPY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MEMBRANE PROTEINS; NEOPLASMS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, ANTIGEN, T-CELL; RETROVIRIDAE; T-LYMPHOCYTES;

EID: 0033639310     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Gene therapy for cancer (present status)
2. Targeting gene therapy to cancer: A review
3. Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery
4. Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody
5. Selective expression of carcinoembryonic antigen promoter in cancer cell lines: Targeting strategy for gene therapy in colorectal cancer
6. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule
7. Biochemical characterization of 25 distinct carcinoembryonic antigen (CEA) epitopes recognized by 57 monoclonal antibodies and categorized into seven groups in terms of domain structure of the CEA molecule
8. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen
9. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model
10. Specific targeting of iNOS gene to CEA producing cancer cells by a retroviral vector displaying anti-CEA scFv
11. Nitric oxide as a secretory product of mammalian cells
12. Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite
13. Missile therapy and immunogene therapy for cancer using carcinoembryonic antigen (CEA) as a target
14. Specific targeting of T-cells to CEA-producing tumor cells through chimeric receptors consisting of anti-CEA scFv antibody and the ζ-chain of human TCR/CD3 complex
15. Improved retroviral vectors for gene transfer and expression
16. A simple solid-phase mutual inhibition assay using biotinylated antigen for analyzing the epitope specificities of monoclonal antibodies
17. Age-related changes in the subsets and functions of human T lymphocytes
18. Possible immunogene therapy for cancer using CEA as a target